02/28/2013 - 5:47pm

Biosimilar medicines have been approved and routinely prescribed in Europe for nearly seven years, and creation of a clear pathway for Food and Drug Administration review and approval of generic versions of bioengineered drugs was enshrined into law in the United States with the passage of the Patient Protection and Affordable Care Act nearly three years ago.

02/28/2013 - 5:47pm

The world market for generic drugs will jump more than 15% this year and reach a global total of $127.8 billion, predicted a report from British market research firm Visiongain.

02/28/2013 - 5:46pm

Pharmacy benefit managers are becoming increasingly adept at leveraging the power of generics to save client healthcare dollars and improve their own standing, reports indicated.

02/28/2013 - 5:46pm

The battle over "pay for delay" continues to heat up, and its resolution likely won't come until the nation's highest court decides on the legality of the practice.

02/28/2013 - 5:46pm

The Food and Drug Administration has set user fee rates for generic drug companies, the agency said Jan. 27.

02/28/2013 - 2:45pm

Mylan had sales of $1.72 billion in fourth-quarter 2012 and $6.8 billion for fiscal year 2012, the generic drug maker said.

02/28/2013 - 1:58pm

Mylan has bought a manufacturer of generic injectables for $1.6 billion, the company said.

02/26/2013 - 1:54pm

Drug maker Ranbaxy Labs has started producing the ingredients for a cholesterol drug while working with the Food and Drug Administration to fix manufacturing issues that led to the recall in November 2012 of several batches of the drug.

02/26/2013 - 10:14am

Greenstone has launched an authorized generic version of a drug used to treat cholesterol.